title: Prevalence of the antiheparin-platelet factor 4 antibody in hemodialysis (HD) patients and its effects upon dialysis access.
authors.forename: K
authors.initials: K
authors.lastname: Wallace
authors.forename: I
authors.initials: I
authors.lastname: Dasgupta
authors.forename: J
authors.initials: J
authors.lastname: Stratton
authors.forename: P
authors.initials: P
authors.lastname: Johnston
authors.forename: R
authors.initials: R
authors.lastname: Parry
mesh_terms: D000906:Antibodies / Q000097:blood*; D004739:England; D004797:Enzyme-Linked Immunosorbent Assay; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology*; D006801:Humans; D015994:Incidence; D010978:Platelet Factor 4 / Q000276:immunology*; D010979:Platelet Function Tests; D015995:Prevalence; D006435:Renal Dialysis / Q000009:adverse effects; D013921:Thrombocytopenia / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D013927:Thrombosis / Q000097:blood / Q000453:epidemiology / Q000209:etiology*
chemical_list: D000906:Antibodies; D010978:Platelet Factor 4; D006493:Heparin